Format

Send to

Choose Destination
See comment in PubMed Commons below
Semin Oncol. 2003 Aug;30(4 Suppl 15):26-33.

Oxaliplatin-based combined-modality therapy for rectal cancer.

Author information

  • 1Department of Radiation Oncolgy, Memorial SLoan-Kettering Cancer Center, New York, NY 10021, USA.

Abstract

There are two conventional treatments for clinically resectable rectal cancer. The first is surgery, and, if the tumor is T3 and/or N1-2, this is followed by postoperative combined-modality therapy. The second, for patients with ultrasound T3 or clinical T4 disease, is preoperative combined-modality therapy followed by surgery and postoperative chemotherapy. In this review, the results of these approaches as well as novel combined-modality approaches using oxaliplatin-based regimens will be presented.

PMID:
14523792
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk